We are live on ! Find out more
SA

Strategic Advocates Portfolio holdings

AUM $25.8M
1-Year Est. Return 36.11%
This Fund
S&P 500
This Quarter Est. Return
+23.62%
1 Year Est. Return
+36.11%
3 Year Est. Return
+103.11%
5 Year Est. Return
10 Year Est. Return
AUM
$25.8M
AUM Growth
+$3.23M
Cap. Flow
+$909
Cap. Flow %
0%
Top 10 Hldgs %
42.51%
Holding
286
New
19
Increased
69
Reduced
67
Closed
27

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.47%
2 Technology 19.07%
3 Industrials 6.77%
4 Consumer Discretionary 3.15%
5 Healthcare 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAIN icon
276
Main Street Capital
MAIN
$5.22B
-33
Closed -$1.75K
MARA icon
277
Marathon Digital Holdings
MARA
$4.42B
-2,028
Closed -$16.5K
PG icon
278
Procter & Gamble
PG
$332B
-13
Closed -$1.88K
PSN icon
279
Parsons
PSN
$4.9B
-332
Closed -$18K
RWT
280
Redwood Trust
RWT
$456M
-4,000
Closed -$22.4K
RYZ
281
Ryerson Holding Corp
RYZ
$1.31B
-513
Closed -$11.5K
SNPS icon
282
Synopsys
SNPS
$76.1B
-5
Closed -$1.98K
VERX icon
283
Vertex
VERX
$1.99B
-1,123
Closed -$13.4K
XLV icon
284
State Street Health Care Select Sector SPDR ETF
XLV
$43.1B
-21
Closed -$3.08K
ZS icon
285
Zscaler
ZS
$26.7B
-77
Closed -$10.8K
SOLS
286
Solstice Advanced Materials
SOLS
$9.78B
-7
Closed -$533

Similar funds

Strategic Advocates's Q2 2026 Portfolio in Review

As of Q2 2026, Strategic Advocates held 286 positions worth $25.8M, up 14% from $22.6M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Strategic Advocates's Q2 2026 filing shows 19 new, 69 increased, 67 reduced and 27 closed positions. Its largest new stake was Lam Research: 250 shares worth $108K. The largest sale was iShares US Healthcare ETF, an estimated $169K.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.

  • Strategic Advocates's largest Q2 2026 buy was Lam Research: 250 shares worth $108K.
  • Strategic Advocates added most to Vanguard High Dividend Yield ETF in Q2 2026, an estimated $232K increase.
  • Strategic Advocates's biggest Q2 2026 reduction was iShares US Healthcare ETF, cutting an estimated $169K.
  • Strategic Advocates fully exited Chevron in Q2 2026, selling an estimated $62.1K.
  • Strategic Advocates's ten largest holdings make up 43% of its $25.8M portfolio in Q2 2026.
  • Strategic Advocates opened 19 new positions and closed 27 in Q2 2026.
  • Strategic Advocates's portfolio value rose 14% quarter-over-quarter to $25.8M.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.